BUSINESS

Acquisition of Long-Listed Drugs to Promote Generic Sales; Sales Target of 50 Billion Yen “in Range”: Kyowa Pharm

December 7, 2016

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Kyowa Pharmaceutical Industry began marketing and detailing 21 long-listed products transferred from Shionogi on December 1. President Ray Tsunoda said in a recent interview with Jiho that with the acquisition the company’s current sales target of 50 billion yen “is…

To read the full story

Shionogi to Transfer 21 Off-Patent Products to Kyowa Pharm
August 3, 2016

BUSINESS

Takeda Turns the Page to Kim’s “10-Year” Era, Betting on New Drugs and AI
June 26, 2026
Sangamo Files Chapter 11, Astellas and Lilly Eye Key Assets
June 26, 2026
Otsuka’s Centanafadine Meets PIII Goal in ADHD Patients with Anxiety
June 26, 2026
Shionogi Welcomes Government Roadmap’s Focus on Infectious Diseases
June 26, 2026
Sawai Cleared to Manufacture Nichi-Iko’s Lipitor Generic
June 26, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…

COMMENTARY

Adaptation, Diversification Key as Drug Wholesalers Face Profit Squeeze

By Tatsuya Otsuka

Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…